Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Psychopharmacology Bulletin
|
October 15, 2016
Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
Arifulla Khan, Mark Joyce, Sarah Atkinson, et al.
Journal of Tropical Pediatrics
|
June 4, 2009
Hypothermia in children with severe malnutrition: low prevalence on the tropical coast of Kenya
Alison Talbert, Sarah Atkinson, Japhet Karisa, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
November 8, 2013
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
March 25, 2014
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Social Science & Medicine (1982)
|
January 14, 2021
Trajectories in mental health and socio-spatial conditions in a time of economic recovery and austerity: A longitudinal study in England 2011-17
Sarah Curtis, Niall Cunningham, Jamie Pearce, et al.
Plos One
|
January 23, 2026
The role of obesity and Type 2 diabetes in lung health: A systematic review (2024)
Roanne Lecky, Svitlana Grogan, Priyank Shukla, et al.
Journal of Clinical Psychopharmacology
|
March 28, 2015
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Susan G Ball, Sarah Atkinson, JonDavid Sparks, et al.
History and Philosophy of the Life Sciences
|
June 29, 2021
Seeing the value of experiential knowledge through COVID-19
Sarah Atkinson, Hannah Bradby, Mariacarla Gadebusch Bondio, et al.
Applied Ergonomics
|
November 29, 2016
Blood sampling - Two sides to the story
Laura Pickup, Sarah Atkinson, Erik Hollnagel, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Psychopharmacology Bulletin
|
October 15, 2016
Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
Arifulla Khan, Mark Joyce, Sarah Atkinson, et al.
Journal of Tropical Pediatrics
|
June 4, 2009
Hypothermia in children with severe malnutrition: low prevalence on the tropical coast of Kenya
Alison Talbert, Sarah Atkinson, Japhet Karisa, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
November 8, 2013
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
March 25, 2014
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, et al.
Social Science & Medicine (1982)
|
January 14, 2021
Trajectories in mental health and socio-spatial conditions in a time of economic recovery and austerity: A longitudinal study in England 2011-17
Sarah Curtis, Niall Cunningham, Jamie Pearce, et al.
Plos One
|
January 23, 2026
The role of obesity and Type 2 diabetes in lung health: A systematic review (2024)
Roanne Lecky, Svitlana Grogan, Priyank Shukla, et al.
Journal of Clinical Psychopharmacology
|
March 28, 2015
Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Susan G Ball, Sarah Atkinson, JonDavid Sparks, et al.
History and Philosophy of the Life Sciences
|
June 29, 2021
Seeing the value of experiential knowledge through COVID-19
Sarah Atkinson, Hannah Bradby, Mariacarla Gadebusch Bondio, et al.
Applied Ergonomics
|
November 29, 2016
Blood sampling - Two sides to the story
Laura Pickup, Sarah Atkinson, Erik Hollnagel, et al.
Page
of 8